Longboard Pharmaceuticals, Inc. (LBPH) Financials

LBPH Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 58.9 million 6.8 million
2023-06-30 66.2 million 8.1 million
2023-03-31 79.7 million 7.6 million
2022-12-31 70.6 million 9.1 million

LBPH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.3 million 856000
2023-06-30 -13.5 million 841000
2023-03-31 -13.1 million 697000
2022-12-31 -9.7 million 592000

LBPH Net Income

No data available :(

LBPH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 56.0 million - 502000
2023-06-30 63.0 million - 589000
2023-03-31 76.1 million - 683000
2022-12-31 67.6 million - 740000

LBPH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 23.5 million
2023-06-30 23.0 million
2023-03-31 20.4 million
2022-12-31 17.2 million

LBPH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 10.5 million 3.1 million -
2023-06-30 - 12.5 million 3.1 million -
2023-03-31 - 8.5 million 3.4 million -
2022-12-31 - 9.2 million 2.5 million -

LBPH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1000
2023-06-30 - 2000
2023-03-31 - 1000
2022-12-31 - 1000

LBPH

Price: $21.38

52 week price:
3.60
28.15

Earnings Per Share: -2.39 USD

P/E Ratio: -8.09

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 65700

Market Capitalization: 794.8 million

Links: